BWM
BSX icon

Bullock Wealth Management’s Boston Scientific BSX Stock Holding History

Bullock Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43K Buy
+126
New +$6.84K ﹤0.01% 498

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bullock Wealth Management's BSX Position: Q2 2026 in Review

Bullock Wealth Management opened a new position in Boston Scientific (BSX) in Q2 2026: 126 shares worth $5.43K. The stake represents ﹤0.01% of the portfolio and ranks #498 among its holdings.

1,465 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bullock Wealth Management held 126 shares of Boston Scientific worth $5.43K as of Q2 2026.
  • Boston Scientific was a new Bullock Wealth Management position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Bullock Wealth Management's portfolio in Q2 2026, its #498 holding.
  • 1,465 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.